BDBM260658 US9533985, 46
SMILES: COc1cc2c(cn1)n(C)c(=O)n(-c1ccc(C[C@H](NC(=O)c3c(F)cc(NS(=O)(=O)c4ccc(cc4)-c4ncccn4)cc3F)C(O)=O)cc1)c2=O
InChI Key: InChIKey=SKOXRBVQVPASFS-MHZLTWQESA-N
Data: 3 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260658 (US9533985, 46) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260658 (US9533985, 46) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-1/Vascular cell adhesion protein 1 (Homo sapiens (Human)) | BDBM260658 (US9533985, 46) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human T-cell line, Jurkat, which is known to express α4β1 integrin, to VCAM-1 w... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair |